Condition: Neurodegenerative Diseases · Parkinson Disease · Synucleinopathies · Sponsor: Casa di Cura San Raffaele Cassino
MARKERS-NDD is a prospective, observational, longitudinal study, which aims to collect data from patients affected by neurodegenerative diseases (NDD) followed longitudinally for routine examinations performed as part of normal clinical practice. Data collected from clinical evaluations, movement analysis, brain imaging, neuropsychological and electroencephalographic assessments, blood chemistry tests will be analysed to carry out statistical investigations and predictive analyses, also using artificial intelligence systems, which allow the identification of new early markers of diagnosis and prognosis of neurodegenerative diseases.
This description comes directly from the study's public registry record.
Maria Francesca De Pandis, MD, PhD, Neurologist · 0776394740 · maria.depandis@sanraffaele.it
Maria Gaglione · 0776394740 · maria.gaglione@sanraffaele.it
Always discuss trial participation with your own doctor first.
| San Raffaele Cassino | Cassino, Frosinone, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06596746